One of the best ways to become a better health journalist is to find out what the best in the biz are doing — and then make it your own. Great health journalism is happening all over the world, and, with his diverse, far-reaching résumé, pediatrician and broadcast journalist Norman Swan demonstrates the breadth of what journalists can accomplish.
You may have recently heard about the multimillion-dollar donation that Bill Gates and Leonard Lauder made to support research into biomarkers for early detection of Alzheimer’s disease and related dementias.
The Diagnostics Accelerator initiative is part of the Alzheimer’s Drug Discovery Foundation’s (ADDF) effort to speed diagnosis and develop drugs that can prevent, treat, and cure the disease. Lauder was an ADDF co-founder. Continue reading
In my most recent post, I recapped what Georgetown University’s Sabrina Corlette, who is also a former Senate health policy aide, told us on an AHCJ webcast about association health plans. This post looks at the second part of the webinar, about short term limited duration plans. Both are options expanded by the Trump administration that may undermine the ACA markets. You can see her slides and listen to the webcast here.
It is worth nothing that health insurance remains very expensive for people who are trying to buy coverage on the individual market who do not quality for income-related subsidies in the ACA exchanges. Continue reading
A mainstay of health reporting is covering outbreaks of foodborne illness, whether it’s salmonella in peanut butter (and its criminal consequences) or listeria in cantaloupes or ice cream. While the Centers for Disease Control and Prevention maintains a robust site documenting food-borne illness outbreaks, by the time the CDC cites a case on its website, the outbreak often already been in the news since potential outbreaks are first investigated by local and state health departments.
How do these smaller agencies decide how and when to publicize details about a suspected or confirmed outbreak? Continue reading
With thousands of medical studies published every day, it’s impossible to cover even 1 percent of them. When you can only choose a tiny fraction of studies to cover — particularly if you freelance or your editor gives you some autonomy and flexibility in this area — how do you decide whether or not to cover a study?
Reasons can vary: Some people focus on the better known “more prestigious” journals, although that approach has its drawbacks. Continue reading